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Abstract (339 words, limit 350 words) 
Background: We aimed to investigate and optimise the acceptability and usefulness of a patient 
leaflet about antibiotic prescribing decisions made during hospitalisation, and to explore individual 
patient experiences and preferences regarding the process of antibiotic prescription ‘review & 
revise’ which is a key strategy to minimise antibiotic overuse in hospitals. 
Methods: In this qualitative study, run within the feasibility study of a large, cluster-randomised 
stepped wedge trial of 36 hospital organisations, a series of semi-structured, think-aloud telephone 
interviews were conducted and data were analysed using thematic analysis. Fifteen adult patients 
who had experienced a recent acute medical hospital admission during which they had been 
prescribed antimicrobials and offered a patient leaflet about antibiotic prescribing were recruited to 
the study.  
Results: Participants reacted positively to the leaflet, reporting that it was both an accessible and 
important source of information which struck the appropriate balance between informing and 
reassuring. Participants all valued open communication with clinicians, and were keen to be involved 
in antibiotic prescribing decisions, with individuals reporting positive experiences regarding 
antibiotic prescription changes or stopping. Many participants had prior experience or knowledge of 
antibiotics and resistance, and generally welcomed efforts to reduce antibiotic usage. Overall, there 
was a feeling that healthcare professionals (HCPs) are trusted experts providing the most 
appropriate treatment for individual patient conditions. 
Conclusions: This study offers novel insights into how patients within secondary care are likely to 
respond to messages advocating a reduction in the use of antibiotics through the ‘review & revise’ 
approach. Due to the level of trust that patients place in their care provider, encouraging HCPs 
within secondary care to engage patients with greater communication and information provision 
could provide great advantages in the drive to reduce antibiotic use. It may also be beneficial for 
HCPs to view patient experiences as cumulative events that have the potential to impact future 
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behaviour around antibiotic use. Finally, pre-testing messages about antibiotic prescribing and 
resistance is vital to dispelling any misconceptions either around effectiveness of treatment for 
patients, or perceptions of how messages may be received. 
Trial Registration: Current Controlled Trials ISRCTN12674243 (10 April 2017) 
http://www.isrctn.com/ISRCTN12674243 
Keywords: antibiotic prescribing, hospital patients, antimicrobial stewardship 
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BACKGROUND 
Antimicrobial resistance (AMR) is an important issue affecting patients worldwide, with impacts on 
both healthcare costs and patient safety (1). Over prescribing of antimicrobials contributes 
significantly to the growing problem of AMR worldwide (2). Up to 50% of antibiotic prescribing may 
be inappropriate either because antibiotics are not indicated, or the agent(s) selected are too broad 
or continued longer than needed (3, 4, 5). In primary care, efforts to minimise antibiotic overuse are 
directed at only starting antibiotic treatment when there is a clear clinical reason to do so (6). In 
secondary care, where patients are more acutely unwell, strategies to optimise antibiotic use involve 
prompt empiric antibiotic therapy while there is diagnostic uncertainty, followed by regular review 
and revise to target and where appropriate, stop antibiotic treatment. In the NHS (National Health 
Service) this strategy is set out in Department of Health guidance, “Start Smart then Focus” (7). Start 
Smart then Focus recommends five decisions prescribers can take reviewing antibiotic therapy; stop, 
continue, move IV to oral, broaden or de-escalate, or move to outpatient intravenous therapy. 
However, controlling antibiotic overuse through review and revise is challenging (8, 9, 10).  
Antibiotic Review Kit (ARK) Hospital is a complex behavioural intervention targeting all healthcare 
professionals (HCPs) involved in prescribing, dispensing or administering antibiotics for acute and 
general medicine adult patients. This paper reports the findings of a set of interviews with patients 
as part of the wider developmental and feasibility work for a full-scale RCT (randomised controlled 
trial) aiming to encourage appropriate and timely stopping of antibiotics that are no longer needed. 
The overall intervention incorporates digital, behavioural, and organisational elements, including 
online training, a decision aid tool to support decision making around antibiotic prescriptions, a 
patient information leaflet, a structure for monitoring and discussing implementation of the 
intervention, detailed implementation guidance, a resources website, and a peer support network 
(11). For the feasibility trial, all intervention elements were implemented in one medium-sized acute 
hospital in the UK. Full details of how ARK was used by healthcare professionals during the study are 
available in a separate publication (12). The qualitative study described here was an investigation of 
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the feasibility and acceptability of the patient leaflet element of the intervention among patients at 
the feasibility study site. This paper details the development and optimisation of the leaflet.  The full 
protocol for the main trial is reported elsewhere (13). 
Evidence from primary care suggests that engaging patients in antibiotic prescribing decisions can 
facilitate reducing antibiotic use (14). In secondary care, while there is evidence that both patients 
and clinicians want an increase in shared decision-making around prescribing (15, 16), it is not yet 
clear whether this shared decision-making could lead to similar reductions in antibiotic use (17). As a 
result, the ARK-Hospital information leaflet aimed to reassure, inform and empower patients about 
potential changes made to their antibiotic prescription. However, there is an absence of research 
evidence to inform the design and use of a patient information leaflet to support the antibiotic 
‘review & revise’ prescribing process within secondary care.  
The aim of this qualitative study was to investigate and optimise the acceptability and usefulness of 
such a patient leaflet in secondary care, ahead of intended use in a full-scale RCT. We also aimed to 
explore and understand individual patient experiences of the ‘review & revise’ process and identify 
patient views and preferences regarding antimicrobial treatment in hospitals to inform both the 
larger trial and any future research in this field.  
METHODS 
Developing the patient information leaflet 
The detail and planning of the ARK-Hospital intervention are described elsewhere (11). The patient 
leaflet was developed iteratively, building initially on previous research (GRACE-INTRO) which drew 
on theory and qualitative user feedback as detailed elsewhere (18) and was designed to be 
understood by readers with lower levels of health literacy. This was further refined by health 
psychologists and clinicians to ensure accuracy of the health messages. Feedback was sought from 
project stakeholders and from members of a public and patient involvement (PPI) group. This 
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feedback included suggestions for ways to improve the look and feel of the leaflet, e.g., by 
incorporating more engaging images, simplifying the layout, and making minor clarifications to the 
text. PPI input was particularly useful in ensuring that the leaflet gave relevant, but accessible 
information about antibiotic resistance and how to present this without causing undue concern. The 
leaflet provides patients with brief information about when antibiotics are used, the possible risks of 
taking antibiotics, the ‘review & revise’ process and advice about what to do when their antibiotics 
are stopped. 
Recruitment 
Ethical approval for the ARK-Hospital implementation study (ISRCTN: 12674243) was obtained from 
the National Research Ethics Committee (REC reference: 17/SC/0034), including feasibility, pilot and 
main trial phases. It is useful to note that for the feasibility, pilot and main trials, neither staff, nor 
patients are individually consented into the study as the overall unit of randomisation and analysis is 
the site or Trust and no data is identifiable. Only for qualitative date collection did we consent staff 
or patients.  As such, participants for this qualitative component were recruited as a convenience 
sample from patients admitted through the Acute Medical Unit (AMU) at the feasibility study site 
(the Royal Sussex County Hospital, Brighton) between June 2017 and February 2018. All participants 
had been prescribed antibiotics during their hospital stay. For most patients, the intervention leaflet 
was given to patients at their time of discharge from hospital, though in a few cases patients 
received the leaflet when a change had been made to their antibiotic prescription. In line with ethics 
requirements, participants were identified and invited to take part in the study at the time of 
discharge by medical staff who introduced the study and provided them with a study information 
sheet explaining that participation was both confidential and voluntary. Medical staff also checked 
that the participant had been given a copy of the leaflet and asked them to keep this for the 
interview. Interested participants completed the consent form and provided contact details to the 
member of medical staff who then posted these details to researchers at the University of 
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Southampton. Researchers then contacted participants to arrange an interview and verbal consent 
and demographic data were collected prior to each interview. A total of 125 patients were 
approached about the study, with 25 providing consent to be contacted by a researcher. Of these 25 
patients, 10 dropped out, either because they no longer wanted to take part by the time of 
interview, or because they could not be contacted. This left a total of 15 study participants. 
Interviews 
The study methodology involved semi-structured, think-aloud (19), telephone interviews, which 
lasted between 20 and 30 minutes. These were conducted by FM and KS, who are PhD qualified, 
research fellows with training and experience of qualitative methods in health research, including 
conducting cognitive interviews. The study participants were not acquainted with the researchers 
prior to the study, but they were informed about the purpose of the study and were made aware 
that the researchers were affiliated with University of Southampton. Participants were initially asked 
a series of open questions to explore their experience and perception of the ‘review & revise’ 
process, including any changes that were made to their antibiotic prescription and perceptions 
about the duration of antibiotic treatment. They were then asked to read, or listen to the 
interviewer read, the patient leaflet (Figure 1) that they had received while in hospital or at the time 
of discharge. Participants were asked to say everything that they were thinking out loud whilst they 
read the leaflet. Several more open-ended questions followed, which explored what participants 
liked or disliked about the leaflet, what they viewed as most relevant, and any suggested changes to 
improve the leaflet. Using a think aloud methodology enabled us to explore participant reactions to 
the leaflet and gain detailed feedback about each aspect of the intervention, allowing us to make 
changes to and optimise the content.  As negative feedback is especially helpful in developing the 
most effective messages, we deliberately elicited this within our study. After an initial nine 
interviews, the leaflet was revised (Figure 2) based on participant feedback before being tested with 
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a further 6 participants, for a total of 15 unique participant interviews. Participants were 
compensated with a £10 shopping voucher for taking part in the study.  
Data analysis 
Interviews were audio recorded and transcribed verbatim. No field notes were made by researchers 
either during or after the interviews and transcripts were not returned to participants. Analysis 
initially focused on identifying any potential barriers to use of the leaflet and interview feedback was 
used to identify any areas where changes might make it more acceptable, engaging or useful. Each 
transcript was reviewed line-by-line to draw out all responses that were either positive or negative 
perceptions of the leaflet (20). Responses were tabulated and each negative comment was reviewed 
to determine whether a change was necessary. If so, the solution was recorded in the table, 
discussed with the wider team and the change was made. Changes were made if they were likely to 
impact on the acceptability of the leaflet or the ‘review & revise’ process. This included exploring 
aspects such as whether the information was perceived as convincing, reassuring and 
comprehensible. The MoSCoW (Must have, Should have, Could have, Would have) criteria were 
used to assess priority (20) and each change was made in line with the common and intervention 
specific guiding principles of the Person-Based Approach (21). Although similar to content analysis, 
the table of changes as illustrated below, has been created specifically for use in intervention 
development. As such, it does not aim to quantify qualitative data, but instead offers a way to 
analyse this intervention feedback in a systematic and efficient manner, often running in parallel 
with in depth thematic analysis (21).  An example of the data tabulation is shown in Table 1. 
Table 1. Example of table of iterative changes made to patient leaflet 
Page or aspect 
of the 
intervention  
Positive 
comments 
Negative 
comments 
Possible 
change 
Reason for 
change 
Agreed 
change  
MoSCoW 
Section titled:  
“What are the 
risks of taking 
antibiotics?” 
 Confusion over 
how antibiotic 
resistant 
bacteria can be 
spread to 
others, e.g. 
Explanation 
of spreading 
antibiotic 
resistant 
bacteria to 
Important to 
behaviour 
change as we 
do not want 
to confuse or 
Changed 
bolded 
text to 
reduce 
any 
concerns 
Must have 
– crucial to 
ensure 
patients 
accurately 
understand 
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“I didn’t realise 
that antibiotic 
resistance can 
spread to 
other 
members of 
the family. I’m 
not quite sure 
what it 
means.” 
others made 
clearer. 
concern 
patients. 
Expert 
clinicians and 
health 
psychologists 
agreed the 
change was 
suitable. 
Repeatedly 
mentioned by 
participants. 
and 
clarified 
text about 
passing on 
resistance 
to others. 
the risks of 
antibiotics. 
 
Each transcript also underwent inductive thematic analysis (22), supported by use of QSR NVivo 11 
software, and was coded into emerging themes, which represented frequent patterns of meaning 
within the dataset. Coding followed the aims of the research, focusing on patients’ experiences and 
perceptions of the ‘review & revise’ process and the acceptability of a patient leaflet. Coding was 
done by FM, an experienced qualitative researcher, with KS reviewing transcripts and codes 
frequently and advising on the development of themes. The final themes were agreed upon by the 
research team through discussion and consensus that saturation had been reached based on the 
completion of 15 interviews. Data collection stopped when no new concerns or themes emerged. 
RESULTS 
Ten (67%) women and five (33%) men participated, with an age range of 50-91 and mean age of 72 
(SD=13.2). All participants spoke English as their first language and reported their cultural 
background as British. Participants had all been discharged from hospital and eight (53%) were still 
taking antibiotics at the time of discharge. Full demographic details are available in Table 2. 
Table 2. Demographic characteristics of the sample (n=15) 
Demographic characteristics Number / Proportion 
of the sample n (%) 
Gender   
Female 10 (67%) 
Male 5 (33%) 
Age   
18-34 years 0 (0%) 
35-54 years 3 (20%) 
55-74 years 
>75 years 
3 (20%) 
9 (60%) 
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Cultural background   
White British/English  15 (100%) 
Other  0 (0%) 
Education   
GCSEs/GNVQs or equivalent 6 (40%) 
A-levels 2 (13%) 
University degree (e.g. BSc, BA, MSc, PhD) 
No exams taken 
Other 
1 (7%) 
6 (40%) 
0 (0%) 
Languages spoken  
English 15 (100%) 
Other 0 (0%) 
Taking antibiotics when discharged  
      Yes 8 (53%) 
      No 5 (33%) 
      Can’t remember/not sure 2 (13%) 
 
Following detailed thematic analysis, 34 subcategories that fell into 12 categories were extracted 
from the transcripts. From these, 4 interlinking themes were identified (Table 3). The participants 
described their perceptions of the leaflet and the impact that it had on their views of treatment. This 
led to discussions about their largely positive experiences of the ‘review & revise’ process, while also 
linking to any existing knowledge of antibiotics and antibiotic resistance. Finally, participants all 
described the trust that they place in HCPs to make treatment decisions, which appeared to mitigate 
any potential concerns around prescriptions being changed or stopped. 
Table 3. Analytical framework for developing categories and themes for patients’ experiences  
Theme 1: Leaflet acceptability and impact on perceptions of treatment 
Category Definition Example Quote 
Positive perceptions of review 
and revise 
Positive feedback given about the 
leaflet as an introduction to the 
‘review & revise’ process. Also 
includes discussion about 
recommending the leaflet to others 
and the overall relevance of the 
leaflet. 
“I think it makes you feel better 
knowing that you’re being checked 
on and deciding whether we’re 
going to need all these antibiotics 
all the time.” (P9, Female, 81) 
New concerns raised about 
resistance 
Any concerns or questions that 
patients discussed regarding 
antibiotic resistance as well as how 
this may impact friends and family. 
“The one thing that would 
probably worry me more than 
anything is that the more 
antibiotics you take the more 
likely you are to spread them to 
other people, such as your family 
and friends.” (P3, Male, 78) 
Timing of when leaflet 
received 
Discussion about perceptions of the 
impact that timing of the leaflet had 
on their input into treatment as well 
“I found that where I had the 
leaflet it was very helpful in 
actually talking to them [HCPs] 
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as perceived relevance of the 
leaflet. 
about what I was being specifically 
treated for.” (P3, Male, 78) 
Theme 2: Experience of review and revise process 
Category Definition Example Quote 
Positive perceptions of initial 
antibiotic prescribing  
Positive perceptions about how 
antibiotics were initially prescribed, 
including reasons for hospitalisation, 
drug mode of delivery, awareness 
(or not) of initial prescription and 
any information given about 
prescription and/or treatment. 
“…when they put me on the 
antibiotics they were telling me 
exactly what they for, how long I 
was going to be on for, and what 
they was doing, and if I’ve got any 
problems with them at all let them 
know and they’d stop them.” (P5, 
Male, 77) 
 
Experience of prescription 
changes 
Feedback about any changes to 
antibiotic prescription. Includes 
discussion about any diagnostic 
testing and results, changes to drug 
mode of delivery and the efficacy of 
treatment. 
“They started me on antibiotics 
and I had about 2 or 3 that day 
and then 2 in the morning, and 
then when they gave me an x-ray 
they realised it wasn’t a chest 
infection, they think it was a viral 
infection. So they cancelled the 
antibiotics.” (P4, Female, 51) 
Patient perceptions of input 
into treatment 
Amount of input patients felt they 
had regarding antibiotic treatment. 
Reflections on whether they had the 
opportunity to ask questions or 
discuss treatment at the time of 
prescribing, or as any changes to 
treatment were made, up until the 
time of discharge.  
“Anything I did want to know, 
people automatically told me if I 
had anything [medications], which 
was really good.” (P14, Female, 
83) 
Theme 3: Existing knowledge of antibiotics 
Category Definition Example Quote 
Positive past experience(s) of 
antibiotic treatment 
Any positive past treatment 
experiences reported by patients. It 
includes aspects of how treatment 
was received, but also treatment 
efficacy.  
“Well obviously, the only thing I 
use them for is if you’ve got an 
infection because then it kills the 
infection; it makes you well again. 
That’s the only thing I know about 
antibiotics.” (P4, Female, 51) 
Negative past experience(s) of 
antibiotic treatment 
Any negative past experiences of 
antibiotic treatment, with discussion 
including problems with treatment, 
particularly the experience of side 
effects. 
“I agree that some antibiotics 
aren’t great, and I know in the 
past I’ve had antibiotics that upset 
your stomach and had to stop 
them or change them. So I’ve said 
in the past, don’t give me that one 
because I don’t like it.” (P1, 
Female, 50) 
Existing concerns about 
antibiotic resistance 
Patients’ existing knowledge of 
antibiotic resistance and the 
concerns that they had about this.  
“You can get immune to them if 
you take too many.  I mean it’s 
pretty obvious, it’s like anything 
else, that they will stop working, 
that’s why I don’t like to take so 
many.” (P2, Female, 65) 
Theme 4: Trust in healthcare professionals  
Category Definition Example Quote 
Positive existing relationship 
with HCPs 
Positive perceptions that patients 
have about their relationship with 
“The doctors and the hospital have 
been very good, because I have 
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HCPs, including previous experience 
of care by GPs and pharmacists, as 
well as positive experiences of care 
during their recent hospital stay.    
been admitted quite a few times. 
They don’t turn around and say oh 
no, not you again, they do treat 
me as a new patient every time.” 
(P2, Female, 65) 
Willingness to take antibiotics Specific discussions about being 
happy to take antibiotic medications 
in hospital, particularly as this is 
often life-saving and not always 
viewed as a ‘choice’ if patients want 
to recover.  
“I understand the risk you have to 
take, but if you’re in a situation 
like I was, where it was life and 
death, you’re going to take a 
chance of taking antibiotics, 
because if I hadn’t taken them I 
would have died.” (P7, Male, 62) 
Positive perceptions of HCPs as 
experts 
Perception of HCPs as experts giving 
each patient the best possible 
treatment. Patients discussed being 
happy to follow expert HCP advice 
about antibiotic treatment, 
including treatment duration, 
changes to treatment, and not 
always needing to feel involved in 
initial antibiotic treatment decisions. 
“I’d be quite happy to accept 
whatever a doctor prescribed for 
me, because they’re the experts 
and I am not.” (P6, Female, 91) 
 
 
This data is an extract of quotes derived from thematic analysis of interviews exploring participants’ 
experiences of the ‘review & revise’ process and provision of an information leaflet in secondary care. 
 
Leaflet acceptability and impact on perceptions of treatment 
During initial interviews, several participants had questions or concerns regarding antibiotic 
resistance, particularly how this can be spread to others. For most, this stemmed from a lack of 
awareness that resistance can be passed on and a lack of clarity about how this happens: 
“I didn’t realise that resistance could spread to others…I’m not quite sure what that means, 
how can it spread…I don’t understand that.” (Patient 2, Female, 65) 
We felt that it was important to address these concerns by making minor revisions to the leaflet in 
consultation with the PPI group. These revisions aimed to reassure readers that when their doctor 
prescribes antibiotics only when really needed, this helps to reduce the likelihood of developing (and 
hence passing on), resistance. Following these revisions, further patient interviews indicated that 
although there was still a lack of awareness around the spread of resistance, concern appeared to 
have been mitigated: 
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“I didn’t realise that antibiotic resistance, you know by me taking it, it could affect somebody 
else…it doesn’t concern me, I just didn’t realise that, but it’s very easy to understand.” 
(Patient 13, Female, 74) 
Overall, the majority of participants reacted positively to the leaflet, explaining that they found it 
“informative” and “easy to read”. Several participants also discussed the importance of being given 
the information that was included in the leaflet: 
“I think it’s a good move to actually inform the public, not just patients, but the general 
public. To inform them about the dangers in the future of antibiotics not working.” (Patient 
11, Male, 77)    
The leaflet was given to some participants when antibiotics were initially prescribed, and to others 
only at the time of discharge from hospital. A couple of participants who received the leaflet during 
discharge mentioned that they may have found it more useful at the time of treatment, but the 
majority felt that it was still of interest and relevance at the time of discharge. In fact, all participants 
reported that they would recommend the leaflet to others and several explained that they had kept 
it to show to family and friends, or as a document that they could refer back to for further 
information. 
Positive experience of ‘review & revise’ process 
Participants all discussed details of their recent stay in hospital, and reflected on their experience of 
the antibiotic ‘review & revise’ process. Many participants had been admitted for very serious 
conditions and spoke about being unaware of their initial antibiotic prescription. Others explained 
that they were started on antibiotics while diagnostic tests were conducted to confirm their 
diagnosis. Regardless of awareness of treatment or a confirmed diagnosis, all participants reported 
positive perceptions of the antibiotic prescribing process, often recognising the importance of 
receiving fast, initial treatment: 
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“I was just told it was a precaution because it was suspected meningitis and obviously I think 
in that case they did the right thing, because meningitis is pretty nasty and can kill.” (Patient 
1, Female, 50) 
Several participants had experienced changes to their antibiotic prescription. For some this meant 
changing to a different mode of delivery, dosage or drug, while for others it meant stopping 
antibiotics altogether. Again, all participants spoke positively about revisions to their prescriptions, 
often mentioning that HCPs had taken time to clearly explain and inform them about these 
decisions: 
“They upped the dosage frequency, and I think they needed to wait to check because they 
said we’re giving you a wide-ranging one, but they may need to adapt it…and the dose had 
changed and it had been explained to me why.” (Patient 15, Female, 50) 
Overall, participants reported perceiving the ‘review & revise’ process to be sensible and felt that 
their experiences matched the description provided by the leaflet. In some cases, participants even 
felt that the leaflet had helped them to make sense of their experiences.  
Existing knowledge of antibiotics and resistance 
All participants had some knowledge of antibiotics and antibiotic resistance and many had past 
experience of antibiotic treatment. Often this had been a positive experience, both in terms of the 
prescribing process and the efficacy of treatment, but several participants had previously 
experienced problems, reporting that certain drugs were less effective or produced side-effects. 
Among those who had more negative experiences, there was still a general feeling of acceptance 
that they were being prescribed antibiotics because they were the most suitable treatment: 
“I agree that some antibiotics aren’t great and I know in the past I’ve had some that upset 
my stomach and had to stop or change them…but I still think you need to take them if you’re 
that ill and sometimes that outweighs the side effects, and sometimes they can give you 
something to counteract a side effect.” (Patient 1, Female, 50) 
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Based both on past experience and references to the media, most participants displayed some 
knowledge of antibiotic resistance. Although they were not necessarily aware of the mechanisms of 
how resistance works, there was a general awareness that resistance is a cause for concern and may 
result in less effective future treatment:  
“If you use it too much it won’t necessarily work when you do need it, you know?” (Patient 
14, Female, 83) 
While participants voiced concerns about growing resistance to antibiotic treatments, these 
appeared to be mitigated by understanding that their current treatment was a necessity. Although 
they were keen to avoid future resistance and reported that they would be happy to reduce their 
use of antibiotics if possible, they perceived antibiotics as having been prescribed to combat a 
serious, often life-threatening, health condition.  
Trust in healthcare professionals 
All participants spoke positively about their relationship with HCPs, both in relation to routine care 
provided by their general practitioner (GP), or their recent care while in hospital. The majority of 
participants reported being given information about their treatment and condition and being 
offered the opportunity to ask any questions. Even among participants who had been unaware of 
the initial prescription, there was a feeling that they had been provided with details about their care 
as soon as they were in a state to respond to the information. Despite the chance to ask questions, 
most participants reported that they did not do this as they had either already been given the 
information they needed, or their condition was improving and they did not have any concerns. 
Overall, participants appeared to place a large amount of trust in HCPs. There was a sense that HCPs 
were seen as experts who had patient care as their main priority. This trust in HCPs appeared to 
mitigate any concerns that participants might have about their treatment, as they were willing to 
follow expert advice even if it meant changing or stopping an antibiotic prescription: 
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“I put my faith in them, that’s fine. If they stop they stop, I’m quite happy. They said ‘do you 
mind if we stop them’, so I thought no, you want them stopped, stop them.” (Patient 5, Male, 
77) 
Several participants explained that although they were happy to be given information about their 
treatment, they understood that often they did not have a real ‘choice’ about taking antibiotics if 
they wanted to recover. Overall, there was a pervasive sense among participants that antibiotics had 
only been prescribed for them because they were really needed.  
DISCUSSION 
This study offers novel insights into how patients in secondary care are likely to respond positively to 
messages advocating a reduction in the use of antibiotics through the ‘review & revise’ approach. 
Within our participant group, the information leaflet was viewed as both acceptable and useful 
without causing undue concern. Individuals reported positive experiences regarding antibiotic 
prescription being changed and stopped. Many participants had prior experience or knowledge of 
antibiotics and resistance, and generally welcomed efforts to reduce antibiotic usage. There was an 
overall feeling among participants that HCPs were trusted experts who were providing the most 
appropriate treatment for their condition.  
Opportunities for improving patient communication and engagement with ‘review & revise’ 
Our findings suggest that informative and balanced messages are useful in helping patients 
understand and accept the ‘review & revise’ antibiotic prescribing process. Communicators can 
ensure that antibiotic messaging is effective in a number of ways. First, messages should incorporate 
evidence-based information, particularly in relation to antibiotic resistance and the safety and 
effectiveness of shorter courses of antibiotic treatment (23). Additionally, they should address 
common patient misperceptions about the mechanisms of resistance. Previous research has shown 
that patients appear to view antibiotic resistance as a wider public health threat, rather than a 
personal one, particularly if they have not taken antibiotics regularly themselves, because they do 
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not see it as something that is transferrable to others (24, 25). The current study builds on these 
findings by including a message about how antibiotic resistance can be passed on to family, friends 
and even pets. Although some patients had questions or concerns about this process and expressed 
a desire to avoid antibiotic treatment if possible, none reported that they would refuse antibiotic 
treatment if it had been deemed necessary by an HCP. This suggests that clear and open messages 
about the spread of resistance may act as welcome and important motivators for the acceptance of 
the ‘review & revise’ prescribing process among patients.  
The long standing and widely held belief that it is important to complete a course of antibiotics to 
prevent AMR was clearly evident in the current study (24, 26). This has been challenged by evidence 
showing that antibiotic treatment courses are often excessive for individual patients (23) and 
analyses suggesting the belief contributes to overuse of antibiotics and increases selection for AMR 
(27). Our study explored reactions to messaging that implicitly suggested that a course of antibiotic 
treatment may not always need to be completed and found that patients accepted this idea. It may 
be that these findings are specific to our patient population who had been recently and acutely ill 
and not always fully aware of all aspects of their treatment. For instance, unlike primary care, a 
patient in secondary care may be aware that they are receiving antibiotics, but not necessarily the 
dosage or the length of their initial prescription. While in hospital, patients are closely monitored by 
HCPs and changes to treatments may be expected during this time. As a result, patients within 
secondary care may be more open to discussing and accepting changes to their antibiotic treatment. 
Primary care research in this area has developed strategies to reduce initial prescribing of 
unnecessary antibiotic courses (28, 29), having shown that antibiotic prescribing increases patient 
intentions to seek medical care for future illness, compared to either not prescribing, or delayed 
prescribing (30, 31). This indicates that antibiotic prescribing decisions can have longer term effects 
on health seeking behaviour, although the potential and feasibility of ‘review and revise’ strategies 
to reduce overuse of antibiotic in secondary care, and how to most effectively communicate this to 
patients, has not been investigated. Given the positive patient reactions to the concept of ‘review 
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and revise’ within the current study, it may be beneficial to explore how this could potentially 
facilitate shared clinician-patient decision making.   
Our study also highlights the importance of testing messages with the target audience. During the 
development of our information leaflet, we addressed a number of questions from HCPs and the 
ethics committee as to the usefulness and responsibility of providing such information to patients. 
There was some uncertainty about whether patients would actually want an information leaflet and 
whether it might cause or increase any concerns about antibiotic treatment or resistance. Our 
findings build on existing research, which has shown that patients within secondary care are keen to 
receive proactive rather than reactive information about antimicrobials, allowing them to feel more 
confident and invested in their care (17). While HCPs may worry about patient reactions, there is a 
growing body of evidence to suggest that shared decision making between patient and HCP could 
have a role to play in educating patients about antimicrobial stewardship and reducing the 
inappropriate use of antibiotics (32, 25). There is also an extensive body of literature examining the 
relationship of trust between patient and HCP and the impact this has on elements such as patient 
satisfaction and treatment adherence (33, 34). Our findings are in line with earlier research which 
shows that secondary care patients place a high level of trust in HCPs and are confident in their 
ability to prescribe antibiotics accurately and only when necessary (25, 35). This trust in HCPs 
combined with the documented want for information and greater patient engagement (17, 35) 
suggests that patients are open and receptive to messages about the ‘review & revise’ process. 
Additionally, our findings are consistent with recent research indicating that patients may find it 
reassuring to be able to share antibiotic treatment information with family (35).  Further research 
into the timing of messages may also be useful as preferences may vary by clinical population or 
setting and could alter acceptability. By testing the key components of messaging with target 
populations, we have the best chance of ensuring maximum effectiveness, while reducing any 
unintentional, negative impacts (36). 
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Finally, this study has helped to provide some recommendations for how the leaflet can be best used 
in the main trial. First, the main trial should make use of the final, updated version of the leaflet, as 
this was developed based on patient feedback as detailed in this paper. Second, study sites in the 
main trial should aim to have a clear plan in place detailing both who will be distributing the leaflet 
and when it should be provided to the patient. The current study indicated that a lack of time and 
resources can make it challenging to find a member of staff to distribute the leaflet. As a result, the 
main study sites may find it useful to address this in their planning to determine the timing and 
staffing that would be most feasible for their site. Finally, where it is not possible to find the 
resources or staffing to distribute a leaflet, main trial sites could consider providing the leaflet in 
another format, such as a poster that is displayed on the wards. Although this may be a less optimal 
format, it may still help to provide patients access to information that they are keen to receive.  
Strengths and limitations 
This in-depth, qualitative study of antibiotic prescribing within secondary care has helped to 
highlight key themes that should be considered when designing future studies, but it does have 
some limitations. Recruitment proved challenging due to many participants having been hospitalised 
for serious health conditions. Although these conditions had improved by the time of discharge and 
recruitment to the study, often participants were still feeling unwell and in some cases were 
readmitted to hospital before an interview could take place. As a result, we may have missed a 
unique set of experiences related to the ‘review & revise’ process among those participants who 
perhaps went on to receive further antibiotic treatment, which could have altered their perceptions 
of the process. It would have been preferable to conduct interviews face to face with participants as 
this could potentially have yielded more in-depth responses, however this was not practical for this 
study because of the necessary restrictions around the recruitment process. In addition, due to the 
unavoidable delay between participant recruitment and interview, not all participants still had a 
copy of the leaflet by the time of interview. Although every effort was made to ensure that they had 
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the leaflet by sending a replacement copy by post or email, in 1 case this was not possible, and the 
researcher decided to read the text over the phone rather than potentially lose the study 
participant. As a result, it is important to consider that this could have had an impact on the 
responses of that participant, however they still provided valuable feedback about the leaflet and 
their overall experiences.  It is also important to note that results of the current study are specific to 
patients within an acute medical unit in a UK secondary care setting and therefore, may not be 
generalisable to other populations outside the UK or in primary care, where there may be a very 
different set of clinical issues. While this feasibility study had only one hospital site, the main trial 
includes 36 sites from healthcare trusts across England, Wales, Scotland and Northern Ireland. Due 
to the differing characteristics of these varied regions, it is likely that other issues may arise that 
were not evident within this feasibility study. These may include elements such as the practicalities 
of who should give the leaflet to patients, when the leaflet should be provided and whether there is 
sufficient budget to print the leaflet. We would suggest that it would be useful for the main trial to 
further understand how and if a patient information leaflet advocating the ‘review & revise’ process 
might be perceived among other hospital populations, e.g. non-acute medical ward. It would also be 
beneficial to consider how a more diverse patient population across different ages and ethnicities 
may react to the leaflet as part of the main trial. Finally, it is possible that there may be some 
response bias among participants who may have felt obliged to provide positive responses regarding 
their perceptions and experiences. 
CONCLUSIONS 
Secondary care patients responded positively to clear, factual information about antimicrobials and 
were keen to receive an information leaflet about antibiotic prescribing and the ‘review & revise’ 
process. Messages and information about antibiotic treatment coming from HCPs were seen as 
welcome and trustworthy, as well as being in the best interest of the patient. As such, encouraging 
HCPs within secondary care to engage patients in greater communication and information provision 
 21 
 
could provide great advantages in the drive to reduce antibiotic use. Pre-testing messages about 
antibiotic prescribing and resistance is vital to dispelling any misconceptions either around 
effectiveness of treatment for patients, or perceptions of how messages may be received. Although 
it is not feasible to pre-test all messages, for all populations, it remains important to test key 
components of messaging in order to ensure maximum optimisation and intervention effectiveness.  
 
List of abbreviations: HCP, Healthcare professional; AMR, antimicrobial resistance; NHS, National 
Health Service; ARK, Antibiotic Review Kit; RCT, randomised controlled trial; PPI, public patient 
involvement; AMU, acute medical unit; GP, general practitioner 
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Figure 1. Original version of leaflet text 
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Figure 2. Final version of leaflet text following revisions 
 
Highlighting indicates areas where text was altered as a result of qualitative data and PPI input. 
